Documents & Downloads

Rilunermin alfa

Fusion Protein

Rilunermin alfa is a recombinant fusion protein that combines the human C-propeptide of alpha1(I) collagen with the C-terminus of mature human tumor necrosis factor-related apoptosis-inducing ligand (TRAIL, also known as Apo2L). This compound exhibits significant pro-apoptotic properties, making it a valuable tool for cancer research. Its potential antineoplastic activities enable further exploration in therapeutic applications aimed at inducing apoptosis in malignant cells.

Out of Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Specifications

Manufacturer	Adooq Bioscience
CAS Number	2254278-53-8
Applications	Fusion Protein
Synonyms	SCB-313

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.